JP2007520553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520553A5 JP2007520553A5 JP2006552145A JP2006552145A JP2007520553A5 JP 2007520553 A5 JP2007520553 A5 JP 2007520553A5 JP 2006552145 A JP2006552145 A JP 2006552145A JP 2006552145 A JP2006552145 A JP 2006552145A JP 2007520553 A5 JP2007520553 A5 JP 2007520553A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- odv
- multiparticulate
- formate
- succinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009472 formulation Methods 0.000 claims 26
- 239000000203 mixture Substances 0.000 claims 26
- KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 claims 16
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 10
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 claims 6
- 229960004688 venlafaxine Drugs 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 4
- 230000002496 gastric effect Effects 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 239000008188 pellet Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 239000001856 Ethyl cellulose Substances 0.000 claims 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 2
- 239000011324 bead Substances 0.000 claims 2
- 230000003111 delayed effect Effects 0.000 claims 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims 2
- 229920001249 ethyl cellulose Polymers 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 229920002319 Poly(methyl acrylate) Polymers 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- ORUUBRMVQCKYHB-UHFFFAOYSA-N butanedioic acid;4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol Chemical compound OC(=O)CCC(O)=O.C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 ORUUBRMVQCKYHB-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000007891 compressed tablet Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 239000011888 foil Substances 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- -1 hypomellose Polymers 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54238404P | 2004-02-06 | 2004-02-06 | |
| PCT/US2005/002215 WO2005077340A1 (en) | 2004-02-06 | 2005-01-25 | Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007520553A JP2007520553A (ja) | 2007-07-26 |
| JP2007520553A5 true JP2007520553A5 (https=) | 2008-02-14 |
Family
ID=34860300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006552145A Withdrawn JP2007520553A (ja) | 2004-02-06 | 2005-01-25 | 多微粒子ｏ−デスメチルベンラファキシン塩およびその使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20050175698A1 (https=) |
| EP (2) | EP2052717A1 (https=) |
| JP (1) | JP2007520553A (https=) |
| KR (1) | KR20060132891A (https=) |
| CN (1) | CN1917860A (https=) |
| AR (1) | AR050230A1 (https=) |
| AU (1) | AU2005212166A1 (https=) |
| BR (1) | BRPI0507372A (https=) |
| CA (1) | CA2554559A1 (https=) |
| CR (1) | CR8535A (https=) |
| EC (1) | ECSP066827A (https=) |
| IL (1) | IL177052A0 (https=) |
| NO (1) | NO20063963L (https=) |
| PA (1) | PA8622601A1 (https=) |
| PE (1) | PE20050771A1 (https=) |
| RU (1) | RU2006127437A (https=) |
| SG (1) | SG149894A1 (https=) |
| SV (1) | SV2005002008A (https=) |
| TW (1) | TW200528092A (https=) |
| WO (1) | WO2005077340A1 (https=) |
| ZA (1) | ZA200606526B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
| PL350924A1 (en) * | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
| AU2002250058B2 (en) | 2001-02-12 | 2007-08-16 | Wyeth Llc | Novel succinate salt of O-desmethyl-venlafaxine |
| US20080103171A1 (en) * | 2004-12-27 | 2008-05-01 | Astellas Pharma Inc. | Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof |
| DE602006010343D1 (de) * | 2005-03-31 | 2009-12-24 | Wyeth Corp | Kombinationsprodukt aus o-desmethylvenlafaxin und bazedoxifen und verwendungen davon |
| WO2007005961A2 (en) * | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| US7595340B2 (en) | 2005-07-15 | 2009-09-29 | Wyeth | Serotonin and norepinephrine reuptake inhibitor and uses thereof |
| US20070014859A1 (en) * | 2005-07-15 | 2007-01-18 | Wyeth | Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate |
| US20070015828A1 (en) * | 2005-07-15 | 2007-01-18 | Wyeth | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof |
| US7687520B2 (en) | 2005-07-15 | 2010-03-30 | Wyeth Llc | Serotonin and norepinephrine reuptake inhibitors and uses thereof |
| TW200806282A (en) * | 2006-05-05 | 2008-02-01 | Wyeth Corp | Solid dosage formulations |
| EP1870395A1 (en) | 2006-06-19 | 2007-12-26 | KRKA, D.D., Novo Mesto | Process for preparation of o-desmethylvenlafaxine and its analogue |
| TR200909798T1 (tr) * | 2007-07-12 | 2010-05-21 | Dr. Reddy's Laboratories Ltd. | O-desmetilvenlafaksin. |
| CA2702664A1 (en) * | 2007-10-16 | 2009-04-23 | Alphapharm Pty Ltd | Controlled-release pharmaceutical formulation |
| US20110046231A1 (en) * | 2007-10-22 | 2011-02-24 | Actavis Group Ptc Ehf | Solid forms of (±)-o-desmethylvenlafaxine salts |
| MX2012010659A (es) | 2010-03-31 | 2013-03-05 | Wockhardt Ltd | Composicion farmaceutica de liberacion modificada que comprende desvenlafaxina o sus sales. |
| KR20140030156A (ko) | 2011-04-12 | 2014-03-11 | 루핀 리미티드 | 방출-조절되는 데스벤라팍신 약학 조성물 |
| WO2013164559A1 (en) * | 2012-05-03 | 2013-11-07 | Cipla Limited | Antiretroviral composition |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3081496A (en) * | 1959-10-15 | 1963-03-19 | John F Moore | Method of forming flexible sheets of cured foamed rubber |
| AT294000B (de) * | 1965-01-11 | 1971-11-10 | Diersch & Schroeder | Verfahren zur Herstellung von Teppichen oder Läufern |
| US3885257A (en) * | 1972-10-30 | 1975-05-27 | Evans Ronald J P | Pressure controlled resilient supporting structure |
| US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| US4603445A (en) * | 1983-09-09 | 1986-08-05 | Span-America Medical Systems, Inc. | Support pad and method of manufacture |
| US5099627A (en) * | 1990-09-28 | 1992-03-31 | Benjamin Obdyke Incorporated | Ventilated roof construction and method |
| US5203703A (en) * | 1991-08-27 | 1993-04-20 | Schneiderman Marc J | Deglutition training method and apparatus |
| US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| US6162309A (en) * | 1998-04-21 | 2000-12-19 | Burlington Industries, Inc. | Reinforced foam backed carpet |
| US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
| PL350924A1 (en) * | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
| WO2000076955A1 (en) * | 1999-06-15 | 2000-12-21 | American Home Products Corporation | Enantiomers of o-desmethyl venlafaxine |
| US6863972B2 (en) * | 2001-01-09 | 2005-03-08 | Crane Plastics Company Llc | Synthetic wood component having a foamed polymer backing |
| AU2002250058B2 (en) * | 2001-02-12 | 2007-08-16 | Wyeth Llc | Novel succinate salt of O-desmethyl-venlafaxine |
| US20030152741A1 (en) * | 2002-02-05 | 2003-08-14 | Robbins Jeffrey L. | Patterned polyurethane foam and a process for the production of tufted goods with patterned foam backing |
| US20030190352A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon Bv | Compositions of venlafaxine base |
| AU2003247515A1 (en) | 2002-06-10 | 2003-12-22 | Wyeth | Novel formate salt of o-desmethyl-venlafaxine |
| JP2004359665A (ja) * | 2003-05-30 | 2004-12-24 | Rohm & Haas Co | 生体利用性増強剤を含有する治療組成物 |
-
2005
- 2005-01-25 AU AU2005212166A patent/AU2005212166A1/en not_active Abandoned
- 2005-01-25 SG SG200900798-0A patent/SG149894A1/en unknown
- 2005-01-25 CA CA002554559A patent/CA2554559A1/en not_active Abandoned
- 2005-01-25 KR KR1020067015668A patent/KR20060132891A/ko not_active Withdrawn
- 2005-01-25 US US11/042,436 patent/US20050175698A1/en not_active Abandoned
- 2005-01-25 BR BRPI0507372-3A patent/BRPI0507372A/pt not_active IP Right Cessation
- 2005-01-25 EP EP09002123A patent/EP2052717A1/en not_active Withdrawn
- 2005-01-25 CN CNA2005800042516A patent/CN1917860A/zh active Pending
- 2005-01-25 WO PCT/US2005/002215 patent/WO2005077340A1/en not_active Ceased
- 2005-01-25 RU RU2006127437/15A patent/RU2006127437A/ru not_active Application Discontinuation
- 2005-01-25 JP JP2006552145A patent/JP2007520553A/ja not_active Withdrawn
- 2005-01-25 AR ARP050100248A patent/AR050230A1/es unknown
- 2005-01-25 EP EP05711931A patent/EP1711167A1/en not_active Withdrawn
- 2005-01-27 TW TW094102533A patent/TW200528092A/zh unknown
- 2005-01-31 PE PE2005000114A patent/PE20050771A1/es not_active Application Discontinuation
- 2005-02-03 PA PA20058622601A patent/PA8622601A1/es unknown
- 2005-02-04 SV SV2005002008A patent/SV2005002008A/es not_active Application Discontinuation
-
2006
- 2006-07-24 IL IL177052A patent/IL177052A0/en unknown
- 2006-07-25 CR CR8535A patent/CR8535A/es not_active Application Discontinuation
- 2006-08-04 ZA ZA200606526A patent/ZA200606526B/xx unknown
- 2006-09-05 NO NO20063963A patent/NO20063963L/no not_active Application Discontinuation
- 2006-09-06 EC EC2006006827A patent/ECSP066827A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520553A5 (https=) | ||
| JP7603091B2 (ja) | 改善された安定性を有するパッケージされた修飾放出ガンマ－ヒドロキシブチラート製剤 | |
| CN109044981B (zh) | 一种普瑞巴林胃漂浮型缓释片及其制备方法 | |
| CN101534792A (zh) | 包含氧可酮的粒剂和口腔崩解片剂 | |
| TW200413006A (en) | Solid dispersions comprising a hygroscopic and/or deliquescent drug | |
| CN101378736A (zh) | 用于口服给药的多微粒药物剂型 | |
| TW201006509A (en) | Compositions comprising weakly basic drugs and controlled-release dosage forms | |
| RU2013105481A (ru) | Комбинированная система доставки с немедленным/замедленным высвобождением для лекарственных средств с коротким периодом полувыведения, в том числе для ремоглифлозина | |
| RU2006127437A (ru) | Соли о-десметилвенлафаксина в виде дисперсных частиц и их применение | |
| JP2009501233A (ja) | バイオアベイラビリティーの高いｏ−デスメチルベンラファキシンスクシネートの経口用遅延放出投薬形態 | |
| CN103717223A (zh) | 含甘磷酸胆碱或者其药学上可接受的盐的缓释药物组合物及其制造方法 | |
| JP2021152050A (ja) | フマル酸ジメチルを含む医薬ビーズ製剤 | |
| CN109310642A (zh) | 美沙拉嗪的口服药物组合物 | |
| CN1161112C (zh) | 含氯雷他定和伪麻黄碱的药物胶囊组合物 | |
| WO2014040548A1 (zh) | 一种美托洛尔的缓释药物及其制备方法 | |
| CN102920707A (zh) | 一种复方抗结核制剂的制备工艺 | |
| CN102626396A (zh) | 一种美托洛尔缓释片剂及其制备方法 | |
| CN109152772A (zh) | 烟酰胺的口服药物组合物 | |
| JP2010001242A (ja) | レバミピド固形製剤及びその製造方法 | |
| JP2003267889A (ja) | 持続性医薬製剤 | |
| WO2016114017A1 (ja) | オルメサルタンメドキソミルを含有するフィルムコーティング錠剤 | |
| ES2444591T3 (es) | Medicamento con el principio activo hidromorfona con estabilidad al almacenamiento mejorada | |
| JP2019034914A (ja) | 良好な徐放性を有する、レボドパ含有小型化錠剤 | |
| WO2011096953A1 (en) | Oral antidepressant formulation with reduced excipient load | |
| JP2014101332A (ja) | 徐放性塩酸アンブロキソール口腔内崩壊錠 |